Dandiss Tech Co.,Ltd

Dandiss technology CO.,LTD is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. The Company has achieved revenue growth rate of over 100% annually since its establishment in 2001. It has been rewarded research grants by the Ministry of Science and Technology for innovative breakthroughs in a number of patented pharmaceutical intermediates.Headquartered in the Center for New Medicine Discovery and Research in Hangzhou , BrightGene is aggressively committed to the commercialization of the following leading products in its rapidly expanding pipeline:Entecavir and intermediates Posaconazole intermediates Fondaparinux sodium intermediate Lapatinib intermediates Pemetrexed disodium and intermediates Aliskiren intermediates In addition, our commitment extends to delivering excellent products and services for ... [详细介绍]